Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis

NCT00424489 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00424489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00424489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
Lead sponsor
Northwestern University
Phase
Phase 1
Overall status
Terminated
Start date
February 28, 2002
Completion date
June 30, 2016
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myasthenia gravis